Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
https://www.zacks.com/stock/news/2261445/penumbra-s-pen-new-launch-to-enhance-blood-clot-removal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2261445
Apr 24, 2024 - Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
0
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
https://www.zacks.com/stock/news/2260548/reasons-why-you-should-retain-healthequity-hqy-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2260548
Apr 23, 2024 - HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
0
GE HealthCare's (GEHC) New Tie-Up to Boost Patient Outcomes
https://www.zacks.com/stock/news/2260545/ge-healthcare-s-gehc-new-tie-up-to-boost-patient-outcomes?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2260545
Apr 23, 2024 - GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.
0
3 Dividend Aristocrats to Take the Edge off Market Volatility
https://www.zacks.com/stock/news/2259379/3-dividend-aristocrats-to-take-the-edge-off-market-volatility?cid=CS-ZC-FT-analyst_blog|investment_ideas-2259379
Apr 22, 2024 - With markets remaining topsy-turvy, it's prudent for astute investors to pick dividend aristocrats like Atmos Energy (ATO), Ecolab (ECL) and SherwinWilliams (SHW) for steady income.
0
Reasons Why You Should Retain Masimo (MASI) Stock for Now
https://www.zacks.com/stock/news/2258633/reasons-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2258633
Apr 19, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
0
CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits
https://www.zacks.com/stock/news/2258579/cvrx-s-cvrx-latest-data-favors-barostim-s-long-term-benefits?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2258579
Apr 19, 2024 - CVRx's (CVRX) announcement of the availability of additional data supporting the long-term benefits of Barostim is likely to lead to improved patient care.
0
Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
https://www.zacks.com/stock/news/2257983/outset-medical-om-inks-multi-year-deal-to-boost-home-dialysis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2257983
Apr 18, 2024 - Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
0
Will Materials ETFs Gain Further as Q1 Earnings Unfold?
https://www.zacks.com/stock/news/2257915/will-materials-etfs-gain-further-as-q1-earnings-unfold?cid=CS-ZC-FT-etf_news_and_commentary-2257915
Apr 18, 2024 - Going into the Q1 earnings season, earnings releases from the sector giants will determine the movement of these funds.
0
International Paper (IP) Inks Deal to Buy DS Smith for $7.4Bn
https://www.zacks.com/stock/news/2257019/international-paper-ip-inks-deal-to-buy-ds-smith-for-7-4bn?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2257019
Apr 17, 2024 - International Paper (IP) confirms that it has entered into a deal to acquire DS Smith, a move that will create a global leader in sustainable packaging solutions.
0
Air Liquide (AIQUY) Expands Biomethane Production in U.S.
https://www.zacks.com/stock/news/2254790/air-liquide-aiquy-expands-biomethane-production-in-u-s?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2254790
Apr 12, 2024 - Air Liquide (AIQUY) expands U.S. biomethane production with two new units, promoting a circular economy and supporting decarbonization efforts.
0
Page 1>